Compliance with medication regimens for mental and physical disorders.
about
Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophreniaOlanzapine depot for schizophreniaUse of the Medication Event Monitoring System to estimate medication compliance in patients with schizophreniaDiscontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs.Pharmacogenetics and outcome with antipsychotic drugsAdherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder - a systematic literature reviewEffect of drug reminder packaging on medication adherence: a systematic review revealing research gapsEffect of a Multi-Dimensional and Inter-Sectoral Intervention on the Adherence of Psychiatric PatientsPatient adherence to medical treatment: a review of reviews.Effectiveness of the Engagement and Counseling for Latinos (ECLA) intervention in low-income Latinos.Prompts to encourage appointment attendance for people with serious mental illness.Epidemiology of psychotropic medication use: comparison of sales, prescriptions and survey data in Iceland.Exercise interventions as an adjunct therapy for psychosis: a critical review.Attitudes toward psychopharmacology among hospitalized patients from diverse ethno-cultural backgroundsMedication adherence levels and differential use of mental-health services in the treatment of schizophreniaNew measures of mental state and behavior based on data collected from sensors, smartphones, and the Internet.Remission in depressed geriatric primary care patients: a report from the PROSPECT study.Integrating type 2 diabetes mellitus and depression treatment among African Americans: a randomized controlled pilot trial.Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies.Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology.Therapeutic drug monitoring of psychotropic medications.Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individualsThe impact of atypical antipsychotic use on obstructive sleep apnea: a pilot study and literature reviewThe appropriateness of routine medication treatment for schizophrenia.Patient compliance with drug therapy in schizophrenia. Economic and clinical issues.Non-adherence to drug therapy and drug acquisition costs in a national population--a patient-based register study.Adherence to medication regimens and participation in dual-focus self-help groupsMedication adherence and its determinants among psychiatric patients in an Ethiopian referral hospital.Adherence to medication for the treatment of psychosis: rates and risk factors in an Ethiopian populationWorld Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects.Compliance as a stable function in the treatment course of bipolar disorder in patients stabilized on olanzapine: results from a 24-month observational study.A comparison of various methods of measuring antidepressant medication adherence among children and adolescents with major depressive disorder in a 12-week open trial of fluoxetine.Comparative effectiveness of risperidone long-acting injectable vs first-generation antipsychotic long-acting injectables in schizophrenia: results from a nationwide, retrospective inception cohort study.Quantitative levels of aripiprazole parent drug and metabolites in urine.Medication nonadherence and psychiatry.Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines.[Review of the guidelines of the Brazilian Medical Association for the treatment of depression (Complete version)].From compliance to concordance: a review of the literature on interventions to enhance compliance with antipsychotic medication.Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder.Subjective and Objective Cognitive Dysfunction in Schizophrenia - is there a Link?
P2860
Q21260279-C967A49C-A26A-4FA3-8440-CFE29F00881BQ24240925-6AC1FC88-68F4-45EE-9D40-CB384760509DQ24674950-C1DF2C71-C42F-4702-A77E-C711D10EE7F2Q25257471-E25840D6-C516-43FE-9BA2-DCE416A12364Q26852807-F3D623C9-85BD-4F7C-948E-559AB39BA230Q26859455-F90D5873-03F6-4B2F-BA56-35EC7A20E809Q26862555-2E06C31B-4D33-490F-BA24-A898D767C01EQ28550045-0C40A944-5ABF-4A62-B51F-46A3A8CBE8D6Q30479993-DC574B23-C4BD-4E8B-92AD-9EEF0950D93EQ30593816-E43D1054-8B7E-43B0-AE34-4E7A6B2CFA0AQ30992652-D1DD1B17-B1F7-404F-89C1-A2B33F4B6D9FQ31144857-E7803D29-67EB-437A-B287-791BECC2B0F8Q33283325-A9ED1006-AA1A-4355-91BA-43EAB3EA8227Q33350392-92233088-F34A-4F57-8552-2CDE5A742937Q33399275-E1A5FCFF-93F0-4B7D-896A-1EB5CCDD430BQ33441840-03D02DC4-E012-472D-BE86-972DFE5A24C5Q33579484-1A824D0E-3AA9-44D3-B2A5-EF0A9604AA2EQ33806994-C4F26C7E-FDB5-41D5-A81E-FCB7AF5F900FQ33857710-5561DDCE-5474-4ECF-8E0F-F697E903823AQ33886704-053E4719-1675-4BE2-8C61-AF4F883DC098Q33888577-133B38A6-0C4F-41A1-82C9-9D5F05E74E58Q33906501-C0E934DF-D0A8-4711-BFEF-58BC40CE82DAQ33924804-122D8E42-1B52-44A1-92F6-77ED1A9A41C2Q33950877-4A175F2C-8E88-4496-B176-1F514420C8F1Q34078005-4C17C49C-84DD-492C-9DD7-B805EE92E1B1Q34084953-D993D5BF-E94D-4EF1-B0EF-5FF3B4C4FD16Q34116847-1C9EFFA0-D735-49C1-A713-855C90C066DCQ34274083-DB4F9601-B36D-49A9-A509-DA5D0E0B1313Q34308009-6E85F4D2-FD24-4619-A3E0-3390BF1411B4Q34315836-4B5C3115-DF03-4914-8249-16EB0A871A48Q34389967-B5CF3894-6D10-4612-9C51-9465F6AE450EQ34399261-DE0821DF-C9FF-4776-97F3-423E9BE0F448Q34436401-F96A057C-B4ED-40E1-9B0F-6A6495077C85Q34459567-2354BBC8-5337-4864-A526-5F5A37D62DD9Q34465134-F91BC0EA-55A2-41FD-A1A6-5C7BA5F685B9Q34590507-78685B5F-5F78-49EC-AC11-4A348A60E636Q34609457-BE4805F8-79FA-4AB8-94D2-36FAAE866560Q34680884-6D2E54AC-5E39-4490-9C51-033CDB2EE11CQ34871885-CD9F4836-0FD3-48C2-ADED-9B1CFA756A02Q35091697-D553551D-FE18-4380-871E-38D7FBE34F1C
P2860
Compliance with medication regimens for mental and physical disorders.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Compliance with medication regimens for mental and physical disorders.
@en
type
label
Compliance with medication regimens for mental and physical disorders.
@en
prefLabel
Compliance with medication regimens for mental and physical disorders.
@en
P356
P1433
P1476
Compliance with medication regimens for mental and physical disorders.
@en
P2093
Rosenheck R
P304
P356
10.1176/PS.49.2.196
P577
1998-02-01T00:00:00Z